Literature DB >> 8969463

8-O-acetylharpagide is a nonsteroidal ecdysteroid agonist.

A Elbrecht1, Y Chen, T Jurgens, O D Hensens, D L Zink, H T Beck, M J Balick, R Borris.   

Abstract

We have identified a novel nonsteroidal ecdysteroid agonist. This compound was isolated from a methanol extract of Ajuga reptans L. (Lamiaceae) and the structure was identified by spectroscopic methods as 8-O-acetylharpagide. We have characterised this compound as an ecdysteroid agonist in a transactivation assay using beta-galactosidase as the reporter gene regulated by ecdysteroid response elements. In this assay, 8-O-acetylharpagide has an EC50 of 22 microM. The compound also competes with tritiated-ponasterone A for binding to the Drosophila ecdysteroid receptor. Finally, it induces differentiation of Drosophila Kc cells as would be expected of an ecdysteroid agonist. This iridoid glycoside is common to several plant species and may play a role in the natural defense mechanisms of plants.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8969463     DOI: 10.1016/0965-1748(95)00103-4

Source DB:  PubMed          Journal:  Insect Biochem Mol Biol        ISSN: 0965-1748            Impact factor:   4.714


  3 in total

1.  A new model for 20-hydroxyecdysone and dibenzoylhydrazine binding: a homology modeling and docking approach.

Authors:  J M Wurtz; B Guillot; J Fagart; D Moras; K Tietjen; M Schindler
Journal:  Protein Sci       Date:  2000-06       Impact factor: 6.725

2.  Identification of ligands and coligands for the ecdysone-regulated gene switch.

Authors:  E Saez; M C Nelson; B Eshelman; E Banayo; A Koder; G J Cho; R M Evans
Journal:  Proc Natl Acad Sci U S A       Date:  2000-12-19       Impact factor: 11.205

3.  Establishment and characterization of an Ostrinia nubilalis cell line, and its response to ecdysone agonists.

Authors:  A Trisyono; C L Goodman; J J Grasela; A H McIntosh; G M Chippendale
Journal:  In Vitro Cell Dev Biol Anim       Date:  2000-06       Impact factor: 2.416

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.